208 related articles for article (PubMed ID: 36375317)
1. Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy.
Liu TT; Yang H; Zhuo FF; Yang Z; Zhao MM; Guo Q; Liu Y; Liu D; Zeng KW; Tu PF
EBioMedicine; 2022 Dec; 86():104353. PubMed ID: 36375317
[TBL] [Abstract][Full Text] [Related]
2. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
3. ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation.
Xu SH; Zhu S; Wang Y; Huang JZ; Chen M; Wu QX; He YT; Chen D; Yan GR
Cell Death Dis; 2018 May; 9(5):479. PubMed ID: 29706618
[TBL] [Abstract][Full Text] [Related]
4. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
[TBL] [Abstract][Full Text] [Related]
5. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
6. An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination.
Jin X; Jin HR; Jung HS; Lee SJ; Lee JH; Lee JJ
J Biol Chem; 2010 Oct; 285(40):30539-47. PubMed ID: 20682767
[TBL] [Abstract][Full Text] [Related]
7. Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
Jordan VN; Ordureau A; An H
Chembiochem; 2023 Aug; 24(16):e202300108. PubMed ID: 37166757
[TBL] [Abstract][Full Text] [Related]
8. ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1.
Zhang Z; Zhong L; Dan W; Chu X; Liu C; Luo X; Wan P; Liu Z; Lu Y; Wang X; Liu B
Int J Med Sci; 2022; 19(2):274-285. PubMed ID: 35165513
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
Thompson JW; Nagel J; Hoving S; Gerrits B; Bauer A; Thomas JR; Kirschner MW; Schirle M; Luchansky SJ
J Biol Chem; 2014 Oct; 289(42):28942-55. PubMed ID: 25147182
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91.
Hanafi M; Chen X; Neamati N
J Med Chem; 2021 Feb; 64(3):1626-1648. PubMed ID: 33506674
[TBL] [Abstract][Full Text] [Related]
11. A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor.
Wang Y; Zheng Z; Zhang J; Wang Y; Kong R; Liu J; Zhang Y; Deng H; Du X; Ke Y
J Biol Chem; 2015 Nov; 290(47):28200-28213. PubMed ID: 26442585
[TBL] [Abstract][Full Text] [Related]
12. Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues.
Ramachandran S; Ciulli A
Curr Opin Struct Biol; 2021 Apr; 67():110-119. PubMed ID: 33271439
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase SCF
Chen F; Zhang C; Wu H; Ma Y; Luo X; Gong X; Jiang F; Gui Y; Zhang H; Lu F
J Biol Chem; 2017 Dec; 292(49):20100-20112. PubMed ID: 29070679
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
J Virol; 2017 May; 91(9):. PubMed ID: 28202763
[TBL] [Abstract][Full Text] [Related]
15. The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.
Hanoun N; Fritsch S; Gayet O; Gigoux V; Cordelier P; Dusetti N; Torrisani J; Dufresne M
J Biol Chem; 2014 Dec; 289(51):35593-604. PubMed ID: 25355311
[TBL] [Abstract][Full Text] [Related]
16. Molecular glues targeting GSPT1 in cancers: A potent therapy.
Zhang D; Lin P; Lin J
Bioorg Chem; 2024 Feb; 143():107000. PubMed ID: 38029571
[TBL] [Abstract][Full Text] [Related]
17. Two distinct E3 ligases, SCF
Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y
FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008
[TBL] [Abstract][Full Text] [Related]
18. Crbn-based molecular Glues: Breakthroughs and perspectives.
An J; Zhang X
Bioorg Med Chem; 2024 Apr; 104():117683. PubMed ID: 38552596
[TBL] [Abstract][Full Text] [Related]
19. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
Cowan AD; Ciulli A
Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
[TBL] [Abstract][Full Text] [Related]
20. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
